The impact of translated reminder letters and phone calls on mammography screening booking rates: Two randomised controlled trials
Autoři:
Alison Beauchamp aff001; Mohammadreza Mohebbi aff005; Annie Cooper aff006; Vicki Pridmore aff006; Patricia Livingston aff003; Matthew Scanlon aff006; Melissa Davis aff006; Jonathan O’Hara aff003; Richard Osborne aff003
Působiště autorů:
Department of Medicine–Western Health, University of Melbourne, Melbourne, Australia
aff001; Australian Institute for Musculoskeletal Science (AIMSS), Melbourne, Australia
aff002; Faculty of Health, Deakin University, Geelong, Australia
aff003; Monash Rural Health, Warragul, Australia
aff004; Biostatistics Unit, Faculty of Health, Deakin University, Geelong, Australia
aff005; BreastScreen Victoria, Melbourne, Australia
aff006; Centre for Global Health and Equity, Faculty of Health, Arts and Design, Swinburne University of Technology, Hawthorn, Australia
aff007
Vyšlo v časopise:
PLoS ONE 15(1)
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pone.0226610
Souhrn
Introduction
Participation in mammographic screening for breast cancer in Australia is approximately 54% among the general population, but screening among women from some culturally and linguistically diverse (CALD) backgrounds is lower. BreastScreen Victoria apply strategies to increase screening including reminder letters and phone calls; however, these are usually provided in English. Using intervention strategies generated from the Ophelia (OPtimise HEalth LIteracy and Access) community co-design process, translated mammography reminder letters and in-language phone calls were tested within two randomised control trials (RCTs).
Methods and analysis
Women aged 50–75 years who were due for their 2-yearly screening mammography (for RCT#1) or were under-screened, i.e. ≥27 months since last screen (for RCT#2) were randomised into intervention or control groups. RCT#1 compared sending women routine reminder letters (English only) with translated (Arabic or Italian) letters. RCT#2 compared reminder telephone calls to women in their preferred language (Arabic or Italian) to no telephone call. The primary outcome for each trial was screening booking rates within 14-days. Primary outcomes were tested using Pearson’s chi-square test. Rates within language group (incidence ratio: IR) were compared using the Cochran-Mantel-Haenszel test.
Results
For RCT#1 (letters) 1,032 women were randomised into the intervention arm or to usual care. Uptake of screening bookings was similar between both groups, with no differences observed by language group. For RCT#2 (phone calls), 195 women were randomised to the intervention group or to usual care. Overall, 64.2% of women in the intervention arm and 6% in the control arm booked a screening appointment within 14 days (p<0.0001). The IR (95%CI) of booking was 10.1 (3.9, 26.3) times higher among Italian women, and 11.6 (2.9, 46.5) times higher among Arabic women in the intervention compared to usual care groups.
Discussion and conclusion
A service improvement initiative derived from community members and breast screen providers was found to be highly effective. This evidence informed the service provider, BreastScreen Victoria, who have implemented these improvements into routine practice to improve screening among CALD groups and reduce health inequalities.
Klíčová slova:
Australia – Cancer screening – Italian people – Language – Arabic people – Breast cancer – Mammography – Telephones
Zdroje
1. Cancer Australia. Breast cancer statistics. https://breast-cancer.canceraustralia.gov.au/statistics Accessed November 2017. 2017.
2. Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L. Effectiveness of breast cancer screening: Systematic review and meta-analysis to update the 2009 U.S. Preventive Services Task Force recommendation. Ann Intern Med 2016;164:244–55. doi: 10.7326/M15-0969 26756588
3. Weedon-Fekjær H, Romundstad PR, Vatten LJ. Modern mammography screening and breast cancer mortality: population study. BMJ: British Medical Journal. 2014;348.
4. Massat NJ, Dibden A, Parmar D, Cuzick J, Sasieni PD, Duffy SW. Impact of Screening on Breast Cancer Mortality: The UK Program 20 Years On. Cancer Epidemiology Biomarkers & Prevention. 2016;25(3):455–62.
5. Qaseem A, Lin JS, Mustafa RA, Horwitch CA, Wilt TJ, for the Clinical Guidelines Committee of the American College of P. Screening for Breast Cancer in Average-Risk Women: A Guidance Statement From the American College of PhysiciansACP Guidance Statement on Breast Cancer Screening in Average-Risk Women. Annals of Internal Medicine. 2019;170(8):547–60. doi: 10.7326/M18-2147 30959525
6. Capodaglio G, Zorzi M, Tognazzo S, Greco A, Michieletto F, Fedato C, et al. Impact of breast cancer screening in a population with high spontaneous coverage with mammography. Tumori Journal. 2018;104(4):258–65. doi: 10.1177/0300891618792439 30079815
7. Myers E, Moorman P, Gierisch J, Havrilesky L, Grimm L, Ghate S, et al. Benefits and Harms of Breast Cancer ScreeningA Systematic Review. JAMA.314(15):1615–34. doi: 10.1001/jama.2015.13183 26501537
8. Bleyer A, Baines C, Miller AB. Impact of screening mammography on breast cancer mortality. International Journal of Cancer. 2016;138(8):2003–12. doi: 10.1002/ijc.29925 26562826
9. Welch H, H. P. Quantifying the Benefits and Harms of Screening Mammography. JAMA Intern Med. 2014;174:448–54. doi: 10.1001/jamainternmed.2013.13635 24380095
10. Australian Institute of Health and Welfare. BreastScreen Australia monitoring report 2018. Cancer series no. 112. Cat. no. CAN 116. Canberra: AIHW. 2018.
11. Cancer Council Australia. National Cancer Control Policy 2018 [Available from: https://wiki.cancer.org.au/policy/Breast_cancer/Screening.
12. Youlden DR, Cramb SM, Dunn NAM, Muller JM, Pyke CM, Baade PD. The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012;36(3):237–48. doi: 10.1016/j.canep.2012.02.007 22459198
13. Ginsburg OM, Fischer HD, Shah BR, Lipscombe L, Fu L, Anderson GM, et al. A population-based study of ethnicity and breast cancer stage at diagnosis in Ontario. Current Oncology. 2015;22(2):97–104. doi: 10.3747/co.22.2359 25908908
14. Weber MF, Banks E, Smith DP, O'Connell D, Sitas F. Cancer screening among migrants in an Australian cohort; cross-sectional analyses from the 45 and Up Study. BMC Public Health. 2009;9:144. doi: 10.1186/1471-2458-9-144 19442312
15. Lam M, Kwok C, Lee M-J. Prevalence and sociodemographic correlates of routine breast cancer screening practices among migrant-Australian women. Australian and New Zealand Journal of Public Health.n/a-n/a.
16. Australian Institute of Health and Welfare. BreastScreen Australia monitoring report 2013–2014,. Canberra, Australia; 2016.
17. DeGuzman PB, Cohn WF, Camacho F, Edwards BL, Sturz VN, Schroen AT. Impact of Urban Neighborhood Disadvantage on Late Stage Breast Cancer Diagnosis in Virginia. Journal of Urban Health. 2017;94(2):199–210. doi: 10.1007/s11524-017-0142-5 28290007
18. Flores YN, Davidson PL, Nakazono TT, Carreon DC, Mojica CM, Bastani R. Neighborhood socio-economic disadvantage and race/ethnicity as predictors of breast cancer stage at diagnosis. BMC Public Health. 2013;13(1):1061.
19. Padilla C, Painblanc F, Soler-Michel P, V. V. Mapping Variation in Breast Cancer Screening: Where to Intervene? International Journal of Environmental Research and Public Health. 2019;16:2274.
20. Lyle G, Hendrie GA, Hendrie D. Understanding the effects of socioeconomic status along the breast cancer continuum in Australian women: a systematic review of evidence. International Journal for Equity in Health. 2017;16:182. doi: 10.1186/s12939-017-0676-x 29037209
21. Farley C, Friedman D, Habtes I, Raskind-Hood C, Adams EK, Becker ER, et al. Screening Mammography in a Public Hospital Serving Predominantly African-American Women. Women's Health Issues. 2015;25(4):322–30. doi: 10.1016/j.whi.2015.02.006 25910513
22. Luque J, Logan A, Soulen G, Armeson K, Garrett D, Davila C, et al. Systematic Review of Mammography Screening Educational Interventions for Hispanic Women in the United States. J Canc Educ. 2018.
23. Lundqvist A, Andersson E, Ahlberg I, Nilbert M, Gerdtham U. Socioeconomic inequalities in breast cancer incidence and mortality in Europe—a systematic review and meta-analysis. The European Journal of Public Health. 2016;26(5):804–13. doi: 10.1093/eurpub/ckw070 27221607
24. O’Hara J, McPhee C, Dodson S, Cooper A, Wildey C, Hawkins M, et al. Barriers to Breast Cancer Screening among Diverse Cultural Groups in Melbourne, Australia. Int J Environ Res Public Health 2018;15(8).
25. Batterham R, Buchbinder R, Beauchamp A, Dodson S, Elsworth G, Osborne R. The OPtimising HEalth LIterAcy (Ophelia) process: study protocol for using health literacy profiling and community engagement to create and implement health reform. BMC Public Health. 2014;14.
26. Bonfill X, Marzo M, Pladevall M, Marti J, Emparanza JI. Strategies for increasing women participation in community breast cancer screening. Cochrane Database Syst Rev. 2001(1):CD002943. doi: 10.1002/14651858.CD002943 11279781
27. Allgood PC, Maxwell AJ, Hudson S, Offman J, Hutchison G, Beattie C, et al. A randomised trial of the effect of postal reminders on attendance for breast screening. British Journal Of Cancer. 2016;114(2):171–6. doi: 10.1038/bjc.2015.451 26784123
28. Baron RC, Melillo S, Rimer BK, Coates RJ, Kerner J, Habarta N, et al. Intervention to Increase Recommendation and Delivery of Screening for Breast, Cervical, and Colorectal Cancers by Healthcare Providers. A Systematic Review of Provider Reminders. American Journal of Preventive Medicine. 2010;38(1):110–7. doi: 10.1016/j.amepre.2009.09.031 20117566
29. Masi CM, Blackman DJ, Peek ME. Interventions to enhance breast cancer screening, diagnosis, and treatment among racial and ethnic minority women. Med Care Res Rev. 2007;64.
30. Donnelly TT, Hwang J. Breast Cancer Screening Interventions for Arabic Women: A Literature Review. Journal of Immigrant and Minority Health. 2015;17(3):925–39. doi: 10.1007/s10903-013-9902-9 23975014
31. Lu M, Moritz S, Lorenzetti D, Sykes L, Straus S, Quan H. A systematic review of interventions to increase breast and cervical cancer screening uptake among Asian women. BMC Public Health. 2012;12:413–. doi: 10.1186/1471-2458-12-413 22676147
32. Offman J, Myles J, Ariyanayagam S, Colorado Z, Sharp M, Cruice M, et al. A telephone reminder intervention to improve breast screening information and access. Public Health. 2014;128(11):1017–22. doi: 10.1016/j.puhe.2014.09.007 25443131
33. S Bell T, K Branston L, G Newcombe R, R Barton G. Interventions to Improve Uptake of Breast Screening in Inner City Cardiff General Practices with Ethnic Minority Lists. Ethnicity & Health. 1999;4(4):277–84.
34. Beach ML, Flood AB, Robinson CM, Cassells AN, Tobin JN, Greene MA, et al. Can language-concordant prevention care managers improve cancer screening rates? Cancer Epidemiology, Biomarkers & Prevention: A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology. 2007;16(10):2058–64.
35. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials. International Journal of Surgery.10(1):28–55. doi: 10.1016/j.ijsu.2011.10.001 22036893
36. BreastScreen Victoria. BreastScreen Victoria Participation Statistics 01 Jul 2014 to 30 Jun 2016. 2017.
37. Wilf-Miron R, Galai N, Gabali A, Lewinhoff I, Tov OS, Lernau O, et al. Organisational efforts to improve quality while reducing healthcare disparities: the case of breast cancer screening among Arab women in Israel. Quality and Safety in Health Care. 2010;19(5):e36. doi: 10.1136/qshc.2008.029645 20558476
38. Kolahi J, Bang H, Park J. Towards a proposal for assessment of blinding success in clinical trials: up‐to‐date review. Community dentistry and oral epidemiology. 2009;37(6):477–84. doi: 10.1111/j.1600-0528.2009.00494.x 19758415
39. Lewis JA. Statistical principles for clinical trials (ICH E9): an introductory note on an international guideline. Stat Med. 1999;18(15):1903–42. doi: 10.1002/(sici)1097-0258(19990815)18:15<1903::aid-sim188>3.0.co;2-f 10440877
40. Hopewell S, Clarke M, Moher D, et al CONSORT Group. CONSORT for reporting randomised trials in journal and conference abstracts. Lancet. 2008;371:281–3. doi: 10.1016/S0140-6736(07)61835-2 18221781
41. Schulz KF, Altman DG, Moher D, Group C. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials. 2010;11:32–. doi: 10.1186/1745-6215-11-32 20334632
42. Katz D, Baptista J, Azen SP, Pike MC. Obtaining Confidence Intervals for the Risk Ratio in Cohort Studies. Biometrics. 1978;34(3):469–74.
43. Duffy SW, Myles JP, Maroni R, Mohammad A. Rapid review of evaluation of interventions to improve participation in cancer screening services. Journal of Medical Screening. 2017;24(3):127–45. doi: 10.1177/0969141316664757 27754937
44. Patel S, Hemmige V, Street RL, Viswanath K, Arya M. Activating Racial and Ethnic Minorities to Engage in Preventive Health: Patient Preferences for Health Reminders. Journal of participatory medicine. 2017;9:e8. 29270330
45. Hegenscheid K, Hoffmann W, Fochler S, Domin M, Weiss S, Hartmann B, et al. Telephone Counseling and Attendance in a National Mammography-Screening Program. American Journal of Preventive Medicine. 2011;41(4):421–7. doi: 10.1016/j.amepre.2011.06.040 21961470
46. Goelen G, De Clercq G, Hanssens S. A community peer-volunteer telephone reminder call to increase breast cancer-screening attendance. Oncology Nursing Forum. 2010;37(4):E312–7. doi: 10.1188/10.ONF.E312-E317 20591795
47. Kiran T, Davie S, Moineddin R, Lofters A. Mailed Letter Versus Phone Call to Increase Uptake of Cancer Screening: A Pragmatic, Randomized Trial. Journal Of The American Board Of Family Medicine: JABFM. 2018;31(6):857–68. doi: 10.3122/jabfm.2018.06.170369 30413542
48. Dietrich AJ, Tobin JN, Cassells A, Robinson CM, Greene MA, Sox CH, et al. Telephone care management to improve cancer screening among low-income women: a randomized, controlled trial. Annals of internal medicine. 2006;144(8):563–71. doi: 10.7326/0003-4819-144-8-200604180-00006 16618953
49. Luckmann R, Savageau JA, Clemow L, Stoddard AM, Costanza ME. A randomized trial of telephone counseling to promote screening mammography in two HMOs. Cancer Detection and Prevention. 2003;27(6):442–50. doi: 10.1016/j.cdp.2003.09.003 14642552
50. Goel A, George J, Burack RC. Telephone reminders increase re-screening in a county breast screening program. Journal Of Health Care For The Poor And Underserved. 2008;19(2):512–21. doi: 10.1353/hpu.0.0025 18469422
Článok vyšiel v časopise
PLOS One
2020 Číslo 1
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Masturbační chování žen v ČR − dotazníková studie
- Nejasný stín na plicích – kazuistika
- Těžké menstruační krvácení může značit poruchu krevní srážlivosti. Jaký management vyšetření a léčby je v takovém případě vhodný?
- Metformin zlepšuje u žen se syndromem polycystických ovarií pravidelnost menstruačního cyklu i hormonální a metabolický profil
Najčítanejšie v tomto čísle
- Psychometric validation of Czech version of the Sport Motivation Scale
- Comparison of Monocyte Distribution Width (MDW) and Procalcitonin for early recognition of sepsis
- Effects of supplemental creatine and guanidinoacetic acid on spatial memory and the brain of weaned Yucatan miniature pigs
- Accelerated sparsity based reconstruction of compressively sensed multichannel EEG signals